Organon (OGN) Tops Q1 EPS by 6c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street lower on AI spending jitters; oil prices rebound
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Organon Reports Results for the First Quarter Ended March 31, 2022
May 5, 2022 7:30 AM EDTFirst quarter 2022 revenue of $1,567 million Net income from continuing operations of $348 million, or $1.36 per diluted share; Adjusted net income from continuing operations of $420 million, or $1.65 per diluted share Adjusted EBITDA of $647 million Board of Directors declares quarterly dividend of $0.28 per share Full year 2022 financial guidance ranges affirmed
JERSEY CITY, N.J.--(BUSINESS WIRE)-- Organon (NYSE: OGN) (the company), today announced its results for the first quarter ended March 31, 2022.
"The first quarter marked a solid start to the year. We continued to expand our Women's Health offerings by... More



